Neelam Dutt, MD
Gynecology · Flint, MINPI 1144257072
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $629 of the $796 with a category attached, or 78.9%. 12 manufacturers reported payments, led by Astellas Pharma US Inc at 28.8% of the total. Reporting peaked in 2022 at $371 and has fallen 64.4% since, to $132 in 2023.
Across 36 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$229
- Aspira Women's Health Inc$137
- AbbVie$119
- Hologic Sales And Service, LLC$75
- Pfizer$60
- Sumitomo Pharma America, Inc.$58
- plus $117 from 6 others
What the payments were for
- Food & beverage$62979%
- Education$16821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 6 | $229 |
| Aspira Women's Health Inc | 2 | $137 |
| AbbVie(2 entities) | 8 | $119 |
| Hologic Sales And Service, LLC | 6 | $75 |
| Pfizer | 4 | $60 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Coopersurgical, Inc. | 2 | $27 |
| Minerva Surgical, Inc | 1 | $27 |
| Myovant Sciences Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Merck | 1 | $15 |
| Organon | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OVA1$111
How this compares
$796 in reported general payments places this provider in the 60th percentile of 50 gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 11 | $566 |
| Clobetasol Propionate | 12 | $225 |
| Fluconazole | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Flint
- Veena KalraFlint$2K
- Jay BermanSouthfield$218K
- John LagrandGrand Rapids$58K
- Noor Dasouki AbualnadiAnn Arbor$47K
- Deborah RussellSaginaw$30K
- Mona FakihDearborn Heights$11K
- Roderick CairgleDetroit$8K
- Lisa CardwellSouthfield$7K
- Michele ThomasSouthfield$6K
- Joseph RakowskiGrosse Pointe$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.